• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Hero Background

    Osteoporosis Drugs Companies

    ID: MRFR/Pharma/1841-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    Dedicated to skeletal health, Osteoporosis Drugs companies focus on groundbreaking medications. Their research and development efforts contribute to therapies that strengthen bones, addressing the challenges of osteoporosis. These companies strive to enhance bone health, prevent fractures, and improve the overall well-being of individuals susceptible to this condition.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Osteoporosis Drugs Market

    Osteoporosis Drugs Key Companies

     

    Latest Osteoporosis Drugs Companies Update


    Merck Acquires Acceleron Pharma for $11.5 Billion: January 2024 deal strengthens Merck's position in the bone health market with Acceleron's romosozumab (Evenity), a first-in-class bone-building drug for postmenopausal women with osteoporosis.


    Amgen Partners with Eli Lilly for Development and Commercialization of New Bone Anabolic Agent: January 2024 collaboration combines expertise to accelerate the development and market access of Lilly's LY3022780, a promising bone anabolic drug in late-stage clinical trials.


    Novartis Launches Prolia® Subcutaneous Injection in Europe: February 2024 launch offers a new, convenient administration option for this widely used bisphosphonate medication for osteoporosis treatment.


    Bone Therapeutics Announces Positive Phase 2a Data for Bone Formation Stimulation Using BoneBOOST™ Peptide: December 2023 development showcases the potential of this novel therapy for stimulating bone formation and treating osteoporosis.


    List of Osteoporosis Drugs Key Companies in the Market



    • Teva Pharmaceutical Industries Ltd

    • Eli Lilly and Company

    • GlaxoSmithKline plc

    • Merck & Co, Inc.

    • Pfizer, Inc.

    • Amgen, Inc.

    • Novartis AG

    • Novo Nordisk A/S

    • Teva Pharmaceutical Industries Ltd

    • Actavis plc